전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-3 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,047 programs
CGTLimited DatastaleBeijing Bio-Targeting Therapeut…Phase 1

Novel oncolytic virus Ad-TD-nsIL12（BioTTT001） (Novel oncolytic virus Ad-TD-nsIL12（BioTTT001）)

High-grade Glioma · High-grade Glioma

#High-gradeGlioma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
ADCLimited DatastaleOxford BioTherapeutics LtdPhase 1

OBT076, a CD205-directed antibody-drug conjugate (OBT076, a CD205-directed antibody-drug conjugate)

Solid Tumor · CD20

#CD20#ADC#Phase1#antibody-drug-conjugate#SolidTumor+1
Trials 1Status Recruiting
AntibodyLimited DatastaleNovartisPhase 3

OFATUMUMAB + DHAP (OFATUMUMAB + DHAP)

Lymphoma, Large-Cell, Diffuse · Lymphoma, Large-Cell, Diffuse

#LymphomaLarge-CellDiffuse#Antibody#Phase3#monoclonal-antibody#Lymphoma+3
Trials 1Status Active
AntibodyLimited DatastaleAbbViePhase 3

adalimumab (Humira, OLE BSA Adalimumab +/- MTX)

Arthritis, Juvenile Idiopathic · Arthritis, Juvenile Idiopathic

#ArthritisJuvenileIdiopathic#Antibody#Phase3#monoclonal-antibody#Arthritis+2
Trials 1Status Active
AntibodyLimited DatastaleAbbViePhase 3

adalimumab (Humira, OLE FD Adalimumab +/- MTX)

Arthritis, Juvenile Idiopathic · Arthritis, Juvenile Idiopathic

#ArthritisJuvenileIdiopathic#Antibody#Phase3#monoclonal-antibody#Arthritis+2
Trials 1Status Active
CGTLimited DatastaleM.D. Anderson Cancer CenterPhase 2

ONC-PluReceptor NK cells (ONC-PluReceptor NK cells)

Recurrent B-Cell Non-Hodgkin Lymphoma; Refractory B-cell Non-Hodgkin Lymphoma · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

OPTIMOX-bevacizumab (OPTIMOX-bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#monoclonal-antibody#MetastaticColorectalCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleZenas BioPharma (USA), LLCPhase 2

Obexelimab (Obexelimab)

Relapsing Multiple Sclerosis · Relapsing Multiple Sclerosis

#RelapsingMultipleSclerosis#Antibody#Phase2#monoclonal-antibody#Zenas
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 1

G (Obinutuzumab, Obinutuzumab (G))

B-Cell Lymphoma; Non-Hodgkin Lymphoma · B-Cell Lymphoma

#B-CellLymphoma#Antibody#Phase1#monoclonal-antibody#Non-HodgkinLymphoma+1
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 1

durvalumab (Imfinzi, Obinutuzumab, naptumomab estafenatox and durvalumab)

ER+ Breast Cancer; Ovarian Cancer · HER2

#HER2#Antibody#Phase1#monoclonal-antibody#ER+BreastCancer+2
Trials 1Status Recruiting
AntibodyLimited DatastaleGenta IncorporatedPhase 2

Oblimersen-rituximab-fludarabine (Oblimersen-rituximab-fludarabine)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#monoclonal-antibody#Genta
Trials 1Status Active
AntibodyLimited DatastaleNovartisPhase 3

daratumumab (Darzalex, Ofatumumab combined with daratumumab)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis · Anti-N-Methyl-D-Aspartate Receptor Encep

#Anti-N-Methyl-D-AspartateRecepto#Antibody#Phase3#monoclonal-antibody#Novartis
Trials 1Status Recruiting
AntibodyLimited DatastaleAssistance Publique Hopitaux De…Phase 2

MEDI9447 (Oleclumab, Oleclumab (MEDI9447))

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#monoclonal-antibody#Assistance
Trials 1Status Recruiting
AntibodyLimited DatastaleTaipei Tzu Chi Hospital, Buddhi…Approved

Omalizimab (Omalizimab)

Asthma Patients · Asthma Patients

#AsthmaPatients#Antibody#Approved#monoclonal-antibody#Taipei
Trials 1Status Active
CGTLimited DatastaleMayo ClinicPhase 1

Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein (Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein)

Anatomic Stage IV Breast Cancer AJCC v8; Invasive Breast Carcinoma · Anatomic Stage IV Breast Cancer AJCC v8

#AnatomicStageIVBreastCancerAJCCv#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleImugene LimitedPhase 1

Oncolytic Virus CF33-expressing hNIS/Anti-PD-L1 Antibody (Oncolytic Virus CF33-expressing hNIS/Anti-PD-L1 Antibody)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Carcinoma · PD-L1

#PD-L1#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleAbbottPhase 3

adalimumab (Humira, Open-labelAdalimumabRescue)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Abbott
Trials 1Status Active
AntibodyLimited DatastaleNational Cancer Centre, Singapo…Phase 2

Oregovomab (Oregovomab)

Epithelial Ovarian Cancer · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#Antibody#Phase2#monoclonal-antibody#National
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

Orelabrutinib and Rituximab (Orelabrutinib and Rituximab)

Follicular Lymphoma; Relapsed and Refractory Follicular Lymphoma · FRα

#FR#Antibody#Phase2#monoclonal-antibody#FollicularLymphoma+2
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

rituximab (Rituxan, Originator rituximab - Rituxan ® or MabThera ®)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active

77 / 103 pages

← PreviousNext →